Home/Filings/4/0000904454-21-000842
4//SEC Filing

Haskel William M. 4

Accession 0000904454-21-000842

CIK 0001178711other

Filed

Dec 14, 7:00 PM ET

Accepted

Dec 15, 8:50 PM ET

Size

9.2 KB

Accession

0000904454-21-000842

Insider Transaction Report

Form 4
Period: 2021-12-13
Haskel William M.
Sr. VP, Sec. & General Counsel
Transactions
  • Sale

    Common Stock

    2021-12-13$4.42/sh4,876$21,552365,649 total
  • Sale

    Common Stock

    2021-12-15$4.27/sh17,178$73,350340,159 total
  • Sale

    Common Stock

    2021-12-14$4.37/sh8,312$36,323357,337 total
Footnotes (4)
  • [F1]Sale of shares to cover personal income tax obligations upon vesting of restricted stock unit award, pursuant to a Rule 10b5-1 trading plan.
  • [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions ranging from $4.31 to $4.52. The Reporting Person undertakes to provide to Paratek Pharmaceuticals, Inc., any security holder of Paratek Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote 2 to this Form 4
  • [F3]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions ranging from $4.20 to $4.48. The Reporting Person undertakes to provide to Paratek Pharmaceuticals, Inc., any security holder of Paratek Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote 3 to this Form 4.
  • [F4]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions ranging from $4.11 to $4.34. The Reporting Person undertakes to provide to Paratek Pharmaceuticals, Inc., any security holder of Paratek Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote 4 to this Form 4.

Issuer

Paratek Pharmaceuticals, Inc.

CIK 0001178711

Entity typeother

Related Parties

1
  • filerCIK 0001524372

Filing Metadata

Form type
4
Filed
Dec 14, 7:00 PM ET
Accepted
Dec 15, 8:50 PM ET
Size
9.2 KB